Presymptom Health

Presymptom Health is a pioneering medtech company that creates diagnostic tests to detect illnesses earlier to help save lives.

Established to exploit a ground-breaking innovation to detect sepsis in patients up to three days before symptoms appear, Presymptom has recently secured nearly £2M of seed funding and support to enable it to conduct its multisite NHS PRECISION clinical trial, which began enrolling in May 2021. The company is developing a clinical diagnostic portfolio that will ultimately include tests for use at both point-of-care and within central laboratory settings.

Find out more


A team led by Mervyn Singer, Professor of Intensive Care Medicine at University College London, and Dr Roman Lukaszewski, Chief Diagnostic Officer at the Defence Science & Technology Laboratory (Dstl) of the UK Ministry of Defence, has just published the results of a pioneering sepsis study.

Read More


Presymptom Health is open to investment discussions to join us on our journey to create a truly revolutionary test for sepsis.

Find out more


Presymptom Health has a development plan to extend its clinical diagnostic test portfolio to include tests for both point of care and within central laboratories.

Find out more

View our latest news and articles

Latest News